000186457 001__ 186457
000186457 005__ 20240229145746.0
000186457 0247_ $$2doi$$a10.1016/j.annonc.2022.11.013
000186457 0247_ $$2pmid$$apmid:36563965
000186457 0247_ $$2ISSN$$a0923-7534
000186457 0247_ $$2ISSN$$a1569-8041
000186457 0247_ $$2altmetric$$aaltmetric:140386702
000186457 037__ $$aDKFZ-2022-03178
000186457 041__ $$aEnglish
000186457 082__ $$a610
000186457 1001_ $$0P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0$$aKrämer, Alwin$$b0$$eFirst author$$udkfz
000186457 245__ $$aCancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
000186457 260__ $$aAmsterdam [u.a.$$bElsevier$$c2023
000186457 3367_ $$2DRIVER$$aarticle
000186457 3367_ $$2DataCite$$aOutput Types/Journal article
000186457 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1677154780_6895
000186457 3367_ $$2BibTeX$$aARTICLE
000186457 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000186457 3367_ $$00$$2EndNote$$aJournal Article
000186457 500__ $$a#EA:A360# / Volume 34, Issue 3, March 2023, Pages 228-246
000186457 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000186457 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000186457 650_7 $$2Other$$aClassification
000186457 650_7 $$2Other$$aESMO Clinical Practice Guideline
000186457 650_7 $$2Other$$adiagnosis
000186457 650_7 $$2Other$$arisk assessment
000186457 650_7 $$2Other$$atreatment
000186457 650_7 $$2Other$$aunknown primary neoplasm
000186457 7001_ $$0P:(DE-He78)c741dc7f974390ad4310349f29aac40b$$aBochtler, T.$$b1$$udkfz
000186457 7001_ $$aPauli, C.$$b2
000186457 7001_ $$aBaciarello, G.$$b3
000186457 7001_ $$0P:(DE-He78)3e76653311420a51a5faeb80363bd73e$$aDelorme, S.$$b4$$udkfz
000186457 7001_ $$aHemminki, K.$$b5
000186457 7001_ $$aMileshkin, L.$$b6
000186457 7001_ $$aMoch, H.$$b7
000186457 7001_ $$aOien, K.$$b8
000186457 7001_ $$aOlivier, T.$$b9
000186457 7001_ $$aPatrikidou, A.$$b10
000186457 7001_ $$aWasan, H.$$b11
000186457 7001_ $$aZarkavelis, G.$$b12
000186457 7001_ $$aPentheroudakis, G.$$b13
000186457 7001_ $$aFizazi, K.$$b14
000186457 7001_ $$aCommittee, ESMO Guidelines$$b15$$eCollaboration Author
000186457 773__ $$0PERI:(DE-600)2003498-2$$a10.1016/j.annonc.2022.11.013$$gp. S092375342204769X$$n3$$p228-246$$tAnnals of oncology$$v34$$x0923-7534$$y2023
000186457 909CO $$ooai:inrepo02.dkfz.de:186457$$pVDB
000186457 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000186457 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c741dc7f974390ad4310349f29aac40b$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000186457 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3e76653311420a51a5faeb80363bd73e$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000186457 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000186457 9141_ $$y2022
000186457 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-09
000186457 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-09
000186457 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANN ONCOL : 2022$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-22
000186457 915__ $$0StatID:(DE-HGF)9950$$2StatID$$aIF >= 50$$bANN ONCOL : 2022$$d2023-10-22
000186457 9201_ $$0I:(DE-He78)A360-20160331$$kA360$$lKKE Mol. Hämatologie/Onkologie$$x0
000186457 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x1
000186457 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x2
000186457 9200_ $$0I:(DE-He78)A360-20160331$$kA360$$lKKE Mol. Hämatologie/Onkologie$$x0
000186457 980__ $$ajournal
000186457 980__ $$aVDB
000186457 980__ $$aI:(DE-He78)A360-20160331
000186457 980__ $$aI:(DE-He78)E010-20160331
000186457 980__ $$aI:(DE-He78)C020-20160331
000186457 980__ $$aUNRESTRICTED